Use of hepatocyte growth factor/scatter factor to increase transplantable human fetal islet cell mass.
Otonkoski
T
T
Whittier Institute for Diabetes and Endocrinology, La Jolla, California 92037.
Beattie
G M
GM
Lopez
A D
AD
Hayek
A
A
D000818:Animals; D002096:C-Peptide / Q000097:blood; D002455:Cell Division / Q000187:drug effects; D002478:Cells, Cultured; D016332:Fetal Tissue Transplantation / Q000502:physiology; D017228:Hepatocyte Growth Factor / Q000494:pharmacology*; D006801:Humans; D007515:Islets of Langerhans / Q000166:cytology* / Q000187:drug effects; D016381:Islets of Langerhans Transplantation / Q000502:physiology; D007668:Kidney; D051379:Mice; D008819:Mice, Nude; D014183:Transplantation, Heterologous; D016042:Transplantation, Heterotopic
D002096:C-Peptide; D017228:Hepatocyte Growth Factor